UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

The Journal of urology, 2006, Vol.175 (1), p.57-62

2006

Volltextzugriff (PDF)

Molecular cloning and immunogenicity of renal cell carcinoma‐associated antigen G250

International journal of cancer, 2000-03, Vol.85 (6), p.865-870

2000

Volltextzugriff (PDF)

Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1529-1537

1997

Volltextzugriff (PDF)

A rabbit model to tissue engineer the bladder

Biomaterials, 2004-04, Vol.25 (9), p.1657-1661

2004

Volltextzugriff (PDF)

Rabbit Urethra Replacement with a Defined Biomatrix or Small Intestinal Submucosa

European urology, 2003-08, Vol.44 (2), p.266-271

2003

Volltextzugriff (PDF)

The effect of antibody protein dose of anti‐renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts

Cancer, 1997-12, Vol.80 (S12), p.2390-2397

1997

Volltextzugriff (PDF)

Two‐step radio‐immunotargeting of renal‐cell carcinoma xenografts in nude mice with anti‐renal‐cell‐carcinoma X anti‐DTPA bispecific monoclonal antibodies

International journal of cancer, 1998-01, Vol.75 (1), p.74-80

1998

Volltextzugriff (PDF)

Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250

Anticancer research, 1999-03, Vol.19 (2A), p.1197

1999

Volltextzugriff (PDF)

Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinoma

The journal of histochemistry and cytochemistry, 1990-03, Vol.38 (3), p.385-392

1990

Volltextzugriff (PDF)

Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells

Journal of immunotherapy, 2007-01, Vol.30 (1), p.116-122

2007

Volltextzugriff (PDF)

Enhanced RCC cell killing with natural killer cells generated from CD34+ hematopoietic progenitor cells combined with mAb cG250

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e1476-e1476

2017

Volltextzugriff (PDF)

117 Predicting clinical response based on ex vivo drug treatment in renal cell carcinoma using kinase activity profiling

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e117-e117

2016

Volltextzugriff (PDF)

Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study

Journal of immunotherapy (1997), 2002-11, Vol.25 (6), p.500-508

2002

Volltextzugriff (PDF)

Pretargeting of renal cell carcinoma : Improved tumor targeting with a bivalent chelate

Cancer research (Chicago, Ill.), 1999-09, Vol.59 (17), p.4400-4405

1999

Volltextzugriff (PDF)

Alterations in Expression of Cadherin–6 and E–Cadherin during Kidney Development and in Renal Cell Carcinoma

European urology, 2000-09, Vol.38 (3), p.331-338

2000

Volltextzugriff (PDF)

Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23 Suppl), p.5864s-5867s

1995

Volltextzugriff (PDF)

Synergistic therapeutic activity of chimeric G250-TNF and IFNγ for the treatment of renal cell cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16009-16009

2008

Volltextzugriff (PDF)

Phase I Radioimmunotherapy of Metastatic Renal Cell Carcinoma with 131I-labeled Chimeric Monoclonal Antibody G250

Clinical cancer research, 1999-10, Vol.5 (10), p.3268s

1999

Volltextzugriff (PDF)

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

The Journal of urology, 2006-01, Vol.175 (1), p.57-62

2006

Volltextzugriff (PDF)

845 - Enhanced RCC cell killing with natural killer cells generated from CD34+ hematopoietic progenitor cells combined with mAb cG250

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e1476-e1476

2017

Volltextzugriff (PDF)

Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer

Neoplasia (New York, N.Y.), 2022-10, Vol.32, p.100826-100826, Article 100826

2022

Volltextzugriff (PDF)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC

Neoplasia (New York, N.Y.), 2015-02, Vol.17 (2), p.215-224

2015

Volltextzugriff (PDF)

Targeted therapy of renal cell carcinoma: Synergistic activity of cG250‐TNF and IFNg

International journal of cancer, 2009-07, Vol.125 (1), p.115-123

2009

Volltextzugriff (PDF)

INTERLEUKIN 6 INHIBITS THE DIFFERENTIATION AND MATURATION OF MONOCYTE DERIVED DENDRITIC CELLS IN RENAL CELL CANCER PATIENTS

European urology supplements : official journal of the European Association of Urology, 2006-09, Vol.5 (14), p.808-808

2006

Volltextzugriff (PDF)

Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX‐specific chimeric monoclonal antibody cG250

BJU international, 2011-01, Vol.107 (1), p.118-125

2011

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Biological And Medical Sciences
(16)
Humans
(15)
Medical Sciences
(15)
Oncology
(11)
Animals
(10)
Carcinoma, Renal Cell - Immunology
(8)
Kidney Neoplasms - Immunology
(8)
Kidneys
(8)
Mice
(8)
Nephrology. Urinary Tract Diseases
(8)
Tumors Of The Urinary System
(8)
Female
(7)
Renal Cell Carcinoma
(6)
Adult
(5)
Antibodies, Monoclonal - Therapeutic Use
(5)
Antigens, Neoplasm - Immunology
(5)
Carcinoma, Renal Cell - Therapy
(5)
Kidney Neoplasms - Pathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

Molecular cloning and immunogenicity of renal cell carcinoma‐associated antigen G250

Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250

A rabbit model to tissue engineer the bladder

Rabbit Urethra Replacement with a Defined Biomatrix or Small Intestinal Submucosa

The effect of antibody protein dose of anti‐renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts

Two‐step radio‐immunotargeting of renal‐cell carcinoma xenografts in nude mice with anti‐renal‐cell‐carcinoma X anti‐DTPA bispecific monoclonal antibodies

Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250

Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinoma

Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells

Enhanced RCC cell killing with natural killer cells generated from CD34+ hematopoietic progenitor cells combined with mAb cG250

117 Predicting clinical response based on ex vivo drug treatment in renal cell carcinoma using kinase activity profiling

Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study

Pretargeting of renal cell carcinoma : Improved tumor targeting with a bivalent chelate

Alterations in Expression of Cadherin–6 and E–Cadherin during Kidney Development and in Renal Cell Carcinoma

Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma

Synergistic therapeutic activity of chimeric G250-TNF and IFNγ for the treatment of renal cell cancer

Phase I Radioimmunotherapy of Metastatic Renal Cell Carcinoma with 131I-labeled Chimeric Monoclonal Antibody G250

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

845 - Enhanced RCC cell killing with natural killer cells generated from CD34+ hematopoietic progenitor cells combined with mAb cG250

Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC

Targeted therapy of renal cell carcinoma: Synergistic activity of cG250‐TNF and IFNg

INTERLEUKIN 6 INHIBITS THE DIFFERENTIATION AND MATURATION OF MONOCYTE DERIVED DENDRITIC CELLS IN RENAL CELL CANCER PATIENTS

Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX‐specific chimeric monoclonal antibody cG250

Suchergebnisse filtern